*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Flucloxacillin is a semi-synthetic <strong>penicillinase-resistant antibiotic</strong> designed to treat infections caused by beta-lactamase-producing staphylococci. Produced via enzymatic acylation of 6-aminopenicillanic acid, its chemical structure ensures stability against bacterial enzymes. The compound features the molecular formula <strong>C19H18ClFN3O5S</strong> and is identified by CAS No. <strong>27807-42-5</strong>.</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceutical Manufacturing:</strong> Bulk synthesis for oral capsules and injectable formulations targeting skin, soft tissue, and respiratory infections.</li>
<li><strong>Veterinary Medicine:</strong> Treatment of mastitis and wound infections in livestock where methicillin-resistant strains are prevalent.</li>
<li><strong>R&D Laboratories:</strong> Reference standard for microbiological potency testing and stability studies in quality control environments.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly contraindicated for patients with documented <strong>penicillin allergy</strong> due to risk of anaphylaxis. Requires storage in a cool, dry environment below 25°C to maintain chemical integrity. Handling must adhere to occupational safety guidelines to prevent sensitization and inhalation exposure.</p>